Insight Molecular Diagnostics Inc. Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 55.42M159.56M100.09M74.89M35.08M
Current Assets
Cash & Equivalents 7.14M32.95M19.99M9.43M8.64M
Short-term Investments 0.68M0.90M0.43M
Cash & Current Investments 7.82M33.85M20.43M9.43M8.64M
Receivables - Net 0.20M1.44M1.40M0.48M1.61M
Receivables 0.20M1.44M1.40M0.48M1.61M
Inventory 0.41M
Prepaid Assets 1.21M0.90M0.98M0.64M0.82M
Current Assets 9.23M39.14M25.54M10.70M11.76M
Non-Current Assets
Construction in Progress 2.09M1.24M2.14M0.73M0.34M
Property, Plant & Equipment (Net) 6.52M8.53M8.67M3.80M3.57M
Long-Term Investments 13.42M
Goodwill 9.19M18.68M9.50M
Intangibles 15.09M61.89M61.89M56.94M15.04M
Goodwill & Intangibles 24.28M80.57M71.39M56.94M15.04M
Other Non-Current Assets 1.70M29.68M2.12M1.70M1.70M
Non-Current Assets 46.19M120.42M74.56M5.44M6.32M
Liabilities
Current Liabilities
Accounts Payables 2.28M2.08M1.82M0.95M2.28M
Payables 2.28M2.08M1.82M0.95M2.28M
Accumulated Expenses 3.47M2.83M2.02M1.65M1.94M
Short term Debt 2.39M1.39M0.11M2.31M0.23M
Total Current Liabilities 9.00M14.12M12.11M7.19M7.28M
Non-Current Liabilities
Non-Current Debt 1.51M
Preferred Stock Liabilities 5.30M5.13M
Liabilities from Discontinued Operations 1.53M2.00M0.04M
Operating Leases 4.31M3.54M2.73M
Other Non-Current Liabilities 7.12M76.68M45.66M39.90M37.71M
Total Non-Current Liabilities 14.82M17.66M14.84M9.40M9.64M
Liabilities
Total Liabilities 21.94M94.35M60.50M49.30M47.35M
Shareholder's Equity
Total Debt 3.90M1.39M0.11M2.31M0.23M
Common Equity 33.48M65.22M34.29M20.47M-12.27M
Shareholder's Equity 33.48M65.22M34.29M20.47M-12.27M
Liabilities and Shareholders Equity 55.42M159.56M100.09M74.89M35.08M
Retained Earnings -123.68M-187.77M-260.68M-289.88M-350.54M
Treasury Shares 0.20M0.12M0.02M0.01M0.10M